APO RESEARCH · REPORT
Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit
Selected research
Market Analysis & Forecast
Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Analysis and Forecast 2026-2032
Market perspective
The global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit include Yuanma Gene, Shihe Medical, Xiamen Feishuo Biotechnology, Burning Rock, Qiuzhen Medical, Novogene, Jinqirui Biotechnology, BGI and Hangzhou Lianchuan Gene, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit, also provides the sales of main regions and countries. Of the upcoming market potential for Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit sales, projected growth trends, production technology, application and end-user industry.
Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Segment by Company
Yuanma Gene
Shihe Medical
Xiamen Feishuo Biotechnology
Burning Rock
Qiuzhen Medical
Novogene
Jinqirui Biotechnology
BGI
Hangzhou Lianchuan Gene
TRUPCR
HLB PanaGene
AmoyDx
Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Segment by Type
Sequencing Method
Fluorescence PCR Method
Other
Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Segment by Application
Clinical
Scientific Research
Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Sequencing Method
- Fluorescence PCR Method
- Other
Applications
- Clinical
- Scientific Research
Companies covered
- Yuanma Gene
- Shihe Medical
- Xiamen Feishuo Biotechnology
- Burning Rock
- Qiuzhen Medical
- Novogene
- Jinqirui Biotechnology
- BGI
- Hangzhou Lianchuan Gene
- TRUPCR
- HLB PanaGene
- AmoyDx
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market by Type
- 1.2.1 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Sequencing Method
- 1.2.3 Fluorescence PCR Method
- 1.2.4 Other
- 1.3 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market by Application
- 1.3.1 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Clinical
- 1.3.3 Scientific Research
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Dynamics
- 2.1 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Industry Trends
- 2.2 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Industry Drivers
- 2.3 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Industry Opportunities and Challenges
- 2.4 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Region
- 3.2.1 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Region (2021-2026)
- 3.2.3 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Region (2027-2032)
- 3.2.4 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Market Share by Region (2021-2032)
- 3.3 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Estimates and Forecasts 2021-2032
- 3.4 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Region
- 3.4.1 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Region (2021-2026)
- 3.4.3 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Region (2027-2032)
- 3.4.4 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Manufacturers
- 4.1.1 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Manufacturers
- 4.2.1 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Manufacturers (2021-2026)
- 4.2.2 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Price by Manufacturers (2021-2026)
- 4.4 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Manufacturers, Product Type & Application
- 4.7 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market CR5 and HHI
- 4.8.2 2025 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Tier 1, Tier 2, and Tier 3
5 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market by Type
- 5.1 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Type
- 5.1.1 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Market Share by Type (2021-2032)
- 5.2 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Type
- 5.2.1 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Type (2021-2032) & (K Units)
- 5.2.3 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Market Share by Type (2021-2032)
- 5.3 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Price by Type
6 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market by Application
- 6.1 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Application
- 6.1.1 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Market Share by Application (2021-2032)
- 6.2 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Application
- 6.2.1 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Application (2021-2032) & (K Units)
- 6.2.3 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Market Share by Application (2021-2032)
- 6.3 Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Price by Application
7 Company Profiles
- 7.1 Yuanma Gene
- 7.1.1 Yuanma Gene Company Information
- 7.1.2 Yuanma Gene Business Overview
- 7.1.3 Yuanma Gene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Yuanma Gene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio
- 7.1.5 Yuanma Gene Recent Developments
- 7.2 Shihe Medical
- 7.2.1 Shihe Medical Company Information
- 7.2.2 Shihe Medical Business Overview
- 7.2.3 Shihe Medical Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Shihe Medical Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio
- 7.2.5 Shihe Medical Recent Developments
- 7.3 Xiamen Feishuo Biotechnology
- 7.3.1 Xiamen Feishuo Biotechnology Company Information
- 7.3.2 Xiamen Feishuo Biotechnology Business Overview
- 7.3.3 Xiamen Feishuo Biotechnology Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Xiamen Feishuo Biotechnology Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio
- 7.3.5 Xiamen Feishuo Biotechnology Recent Developments
- 7.4 Burning Rock
- 7.4.1 Burning Rock Company Information
- 7.4.2 Burning Rock Business Overview
- 7.4.3 Burning Rock Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Burning Rock Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio
- 7.4.5 Burning Rock Recent Developments
- 7.5 Qiuzhen Medical
- 7.5.1 Qiuzhen Medical Company Information
- 7.5.2 Qiuzhen Medical Business Overview
- 7.5.3 Qiuzhen Medical Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Qiuzhen Medical Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio
- 7.5.5 Qiuzhen Medical Recent Developments
- 7.6 Novogene
- 7.6.1 Novogene Company Information
- 7.6.2 Novogene Business Overview
- 7.6.3 Novogene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Novogene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio
- 7.6.5 Novogene Recent Developments
- 7.7 Jinqirui Biotechnology
- 7.7.1 Jinqirui Biotechnology Company Information
- 7.7.2 Jinqirui Biotechnology Business Overview
- 7.7.3 Jinqirui Biotechnology Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Jinqirui Biotechnology Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio
- 7.7.5 Jinqirui Biotechnology Recent Developments
- 7.8 BGI
- 7.8.1 BGI Company Information
- 7.8.2 BGI Business Overview
- 7.8.3 BGI Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 BGI Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio
- 7.8.5 BGI Recent Developments
- 7.9 Hangzhou Lianchuan Gene
- 7.9.1 Hangzhou Lianchuan Gene Company Information
- 7.9.2 Hangzhou Lianchuan Gene Business Overview
- 7.9.3 Hangzhou Lianchuan Gene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 Hangzhou Lianchuan Gene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio
- 7.9.5 Hangzhou Lianchuan Gene Recent Developments
- 7.10 TRUPCR
- 7.10.1 TRUPCR Company Information
- 7.10.2 TRUPCR Business Overview
- 7.10.3 TRUPCR Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 TRUPCR Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio
- 7.10.5 TRUPCR Recent Developments
- 7.11 HLB PanaGene
- 7.11.1 HLB PanaGene Company Information
- 7.11.2 HLB PanaGene Business Overview
- 7.11.3 HLB PanaGene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.11.4 HLB PanaGene Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio
- 7.11.5 HLB PanaGene Recent Developments
- 7.12 AmoyDx
- 7.12.1 AmoyDx Company Information
- 7.12.2 AmoyDx Business Overview
- 7.12.3 AmoyDx Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.12.4 AmoyDx Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Product Portfolio
- 7.12.5 AmoyDx Recent Developments
8 North America
- 8.1 North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size by Type
- 8.1.1 North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Type (2021-2032)
- 8.1.2 North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Type (2021-2032)
- 8.1.3 North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Price by Type (2021-2032)
- 8.2 North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size by Application
- 8.2.1 North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Application (2021-2032)
- 8.2.2 North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Application (2021-2032)
- 8.2.3 North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Price by Application (2021-2032)
- 8.3 North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size by Country
- 8.3.1 North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size by Type
- 9.1.1 Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Type (2021-2032)
- 9.1.2 Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Type (2021-2032)
- 9.1.3 Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Price by Type (2021-2032)
- 9.2 Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size by Application
- 9.2.1 Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Application (2021-2032)
- 9.2.2 Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Application (2021-2032)
- 9.2.3 Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Price by Application (2021-2032)
- 9.3 Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size by Country
- 9.3.1 Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size by Type
- 10.1.1 China Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Type (2021-2032)
- 10.1.2 China Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Type (2021-2032)
- 10.1.3 China Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Price by Type (2021-2032)
- 10.2 China Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size by Application
- 10.2.1 China Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Application (2021-2032)
- 10.2.2 China Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Application (2021-2032)
- 10.2.3 China Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size by Type
- 11.1.1 Asia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Type (2021-2032)
- 11.1.2 Asia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Type (2021-2032)
- 11.1.3 Asia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Price by Type (2021-2032)
- 11.2 Asia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size by Application
- 11.2.1 Asia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Application (2021-2032)
- 11.2.2 Asia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Application (2021-2032)
- 11.2.3 Asia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Price by Application (2021-2032)
- 11.3 Asia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size by Country
- 11.3.1 Asia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size by Type
- 12.1.1 SAMEA Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Type (2021-2032)
- 12.1.2 SAMEA Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Type (2021-2032)
- 12.1.3 SAMEA Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Price by Type (2021-2032)
- 12.2 SAMEA Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size by Application
- 12.2.1 SAMEA Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue by Application (2021-2032)
- 12.2.2 SAMEA Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Application (2021-2032)
- 12.2.3 SAMEA Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Price by Application (2021-2032)
- 12.3 SAMEA Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size by Country
- 12.3.1 SAMEA Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Value Chain Analysis
- 13.1.1 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Production Mode & Process
- 13.2 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Distributors
- 13.2.3 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst